cancer research

Researchers report observing a deadly brain cancer physically remodel brain tissue as the tumor grows. The findings offer a rare real-time view of how glioblastoma-type cancers distort and reorganize the brain, potentially improving understanding of disease progression and treatment approaches.

Part two of a roundup of highlights from the World Cancer Congress 2026 has been published, covering key presentations, research findings and discussions from the global oncology meeting. The continued coverage suggests sustained interest in developments presented at the congress among cancer researchers and clinicians worldwide.

A new report outlines how biological research is changing the way breast cancer is diagnosed and treated. Understanding tumour biology is increasingly guiding treatment choices, moving care away from one-size-fits-all approaches toward therapies matched to the specific characteristics of each patient's cancer. The piece has drawn attention from clinicians and patient advocates following shifts in treatment standards.

The World Cancer Congress 2026 is drawing attention with a roundup of its key moments and announcements. Coverage so far focuses on highlights from the global gathering of cancer researchers, clinicians and advocates, though specific findings or policy outcomes have not yet been detailed. Interest is expected to grow as sessions conclude and results are shared.

Researchers have highlighted three previously overlooked RNA molecules as potential new markers for colorectal cancer. The findings suggest these molecules could help detect the disease earlier and guide treatment choices, offering a possible addition to existing screening and diagnostic tools. Colorectal cancer remains one of the most common cancers worldwide, so any lead on earlier detection is drawing scientific and media attention.

The Trump administration has committed more than $5 billion to the Genesis Mission, an initiative aimed at advancing cancer research, semiconductor development, and quantum computing. The funding package ties together healthcare and advanced technology priorities under a single federal program. Reaction so far has focused on the scale of the commitment and its potential to accelerate US leadership in chips and quantum research while supporting cancer-focused science.

IBA and Penn Medicine have announced the creation of Noventra Oncology Alliance, a joint venture focused on oncology. The partnership combines IBA's technology background with Penn Medicine's clinical and research expertise to develop and advance cancer treatment solutions. Details on funding, leadership and the venture's first programs have not yet been made public.

Dr. Ilyas Sahin has drawn attention to a new scientific study on colorectal cancer liver metastasis, one of the most common and difficult sites of colorectal cancer spread. The findings are being shared among oncology watchers interested in how the disease progresses and what new treatment approaches might follow.

Iowa State University researchers are working on ways to reduce firefighters' elevated risk of cancer, which has been linked to exposure to toxic chemicals and smoke on the job. The Gazette reports on the effort, which comes as firefighting is increasingly recognised as a hazardous occupation with higher cancer rates than the general population.

UT Health San Antonio is working to find a cure for liver cancer, a disease affecting communities across South Texas at elevated rates. The health institution's research efforts were highlighted in local coverage, drawing attention to the region's particular vulnerability and the push for better treatments.